Tagged with regulatory

3 Key Takeaways from Europe’s Premier Regulatory Conference
Defining Gene Therapy Medicinal Products in the EU: Scientific & Regulatory Perspectives
2023: A Pivotal Year for SwissMedic
2023 FDA Drug Approvals: Second Highest Count in 30 Years
Japanese Academic Clinical Data Can Now Be Used for Drug Registration
Regulatory Focus: Brazil’s ANVISA
Camilia Benani – Partner, DLA Piper Morocco
Hong Kong: Towards a Fully-Fledged Regulator of its Own?
Sara Al Dallal – President, Emirates Health Economics Society
New EFPIA Board Tackles EU Pharma Legislation Reform
Can the UK’s New Life Sciences Plan Save Its Global Relevance?
Four Industry Leaders on Middle East Regulatory & Access Trends
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here